Report Detail

Request for Sample of this report

Other Global Low Molecular Weight Heparin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3211193
    • |
  • 29 March, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Scope of the Report:
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
The worldwide market for Low Molecular Weight Heparin is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 380 million US$ in 2024, from 270 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Low Molecular Weight Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Market Segment by Applications, can be divided into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Low Molecular Weight Heparin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin, with price, sales, revenue and global market share of Low Molecular Weight Heparin in 2017 and 2018.
Chapter 3, the Low Molecular Weight Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Low Molecular Weight Heparin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Low Molecular Weight Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Low Molecular Weight Heparin Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Enoxaparin
      • 1.2.2 Dalteparin
      • 1.2.3 Tinzaparin
      • 1.2.4 Fraxiparine
    • 1.3 Market Analysis by Applications
      • 1.3.1 Treatment of Venous Thromboembolism
      • 1.3.2 Complications of Pregnancy
      • 1.3.3 Cardioversion of Atrial Fibrillation/Flutter
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Aspen
      • 2.1.1 Business Overview
      • 2.1.2 Low Molecular Weight Heparin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi-aventis
      • 2.2.1 Business Overview
      • 2.2.2 Low Molecular Weight Heparin Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer
      • 2.3.1 Business Overview
      • 2.3.2 Low Molecular Weight Heparin Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Opocrin
      • 2.4.1 Business Overview
      • 2.4.2 Low Molecular Weight Heparin Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 CSBIO
      • 2.5.1 Business Overview
      • 2.5.2 Low Molecular Weight Heparin Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Dongying Tiandong Pharmaceutical
      • 2.6.1 Business Overview
      • 2.6.2 Low Molecular Weight Heparin Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Changzhou Qianhong Bio-pharma
      • 2.7.1 Business Overview
      • 2.7.2 Low Molecular Weight Heparin Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Techdow
      • 2.8.1 Business Overview
      • 2.8.2 Low Molecular Weight Heparin Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Yantai Dongcheng Pharmaceutical Group
      • 2.9.1 Business Overview
      • 2.9.2 Low Molecular Weight Heparin Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Low Molecular Weight Heparin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Low Molecular Weight Heparin Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Low Molecular Weight Heparin Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Low Molecular Weight Heparin Market Analysis by Regions

    • 4.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 4.3 Europe Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 4.5 South America Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    5 North America Low Molecular Weight Heparin by Country

    • 5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country
      • 5.1.1 North America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 5.3 Canada Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    6 Europe Low Molecular Weight Heparin by Country

    • 6.1 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 6.3 UK Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 6.4 France Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 6.5 Russia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 6.6 Italy Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Low Molecular Weight Heparin by Country

    • 7.1 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)
    • 7.2 China Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 7.3 Japan Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 7.4 Korea Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 7.5 India Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    8 South America Low Molecular Weight Heparin by Country

    • 8.1 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Country
      • 8.1.1 South America Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Low Molecular Weight Heparin by Countries

    • 9.1 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Low Molecular Weight Heparin Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Low Molecular Weight Heparin Sales and Growth Rate (2014-2019)

    10 Global Low Molecular Weight Heparin Market Segment by Type

    • 10.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2014-2019)
    • 10.2 Enoxaparin Sales Growth and Price
      • 10.2.1 Global Enoxaparin Sales Growth (2014-2019)
      • 10.2.2 Global Enoxaparin Price (2014-2019)
    • 10.3 Dalteparin Sales Growth and Price
      • 10.3.1 Global Dalteparin Sales Growth (2014-2019)
      • 10.3.2 Global Dalteparin Price (2014-2019)
    • 10.4 Tinzaparin Sales Growth and Price
      • 10.4.1 Global Tinzaparin Sales Growth (2014-2019)
      • 10.4.2 Global Tinzaparin Price (2014-2019)
    • 10.5 Fraxiparine Sales Growth and Price
      • 10.5.1 Global Fraxiparine Sales Growth (2014-2019)
      • 10.5.2 Global Fraxiparine Price (2014-2019)

    11 Global Low Molecular Weight Heparin Market Segment by Application

    • 11.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2014-2019)
    • 11.2 Treatment of Venous Thromboembolism Sales Growth (2014-2019)
    • 11.3 Complications of Pregnancy Sales Growth (2014-2019)
    • 11.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2014-2019)
    • 11.5 Others Sales Growth (2014-2019)

    12 Low Molecular Weight Heparin Market Forecast (2019-2024)

    • 12.1 Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Low Molecular Weight Heparin Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Low Molecular Weight Heparin Market Forecast (2019-2024)
      • 12.2.2 Europe Low Molecular Weight Heparin Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Low Molecular Weight Heparin Market Forecast (2019-2024)
      • 12.2.4 South America Low Molecular Weight Heparin Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Low Molecular Weight Heparin Market Forecast (2019-2024)
    • 12.3 Low Molecular Weight Heparin Market Forecast by Type (2019-2024)
      • 12.3.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Low Molecular Weight Heparin Market Share Forecast by Type (2019-2024)
    • 12.4 Low Molecular Weight Heparin Market Forecast by Application (2019-2024)
      • 12.4.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Low Molecular Weight Heparin Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Low Molecular Weight Heparin . Industry analysis & Market Report on Low Molecular Weight Heparin is a syndicated market report, published as Global Low Molecular Weight Heparin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Low Molecular Weight Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,225.96
      		4,838.94
      		6,451.92
      		542,984.40
      		814,476.60
      		1,085,968.80
      		290,649.60
      		435,974.40
      		581,299.20
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo